SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escapeTyler N. Starr, Gyorgy Snell|Nature|2021Cited by 582
Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in miceAndrew C. Hunt, David Baker, Rita E. Chen et al.|Science Translational Medicine|2022Cited by 118
A SARS-CoV-2 variant elicits an antibody response with a shifted immunodominance hierarchyAllison J. Greaney, Jesse D. Bloom, Tyler N. Starr et al.|PLoS Pathogens|2022Cited by 80
A potent pan-sarbecovirus neutralizing antibody resilient to epitope diversificationLaura E. Rosen, Tyler N. Starr|Cell|2024Cited by 63
Deep mutational scans of XBB.1.5 and BQ.1.1 reveal ongoing epistatic drift during SARS-CoV-2 evolutionAshley L. Taylor, Tyler N. Starr|PLoS Pathogens|2023Cited by 55